| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 1899 |
| 1 | RIBAVIRIN | 967 |
| 2 | SOFOSBUVIR | 911 |
| 3 | BEVACIZUMAB | 809 |
| 4 | REGORAFENIB | 488 |
| 5 | LEDIPASVIR AND SOFOSBUVIR | 402 |
| 6 | TACROLIMUS | 307 |
| 7 | CABOZANTINIB | 264 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 255 |
| 9 | TACROLIMUS OINTMENT 0.1% | 255 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORAFENIB | 1899 | 0.0917 |
| 1 | NITISINONE | 61 | 0.0638 |
| 2 | SOFOSBUVIR | 911 | 0.0464 |
| 3 | REGORAFENIB | 488 | 0.0420 |
| 4 | ADEFOVIR DIPIVOXIL | 34 | 0.0268 |
| 5 | LEDIPASVIR AND SOFOSBUVIR | 402 | 0.0210 |
| 6 | ENTECAVIR | 216 | 0.0183 |
| 7 | RIBAVIRIN | 967 | 0.0151 |
| 8 | VELPATASVIR AND SOFOSBUVIR | 118 | 0.0092 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 69 | 0.0080 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 61 | 0.0739 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1436 | 0.0274 |
| 2 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 574 | 0.0119 |
| 4 | Nucleoside Analog Antiviral [EPC] | 976 | 0.0114 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 881 | 0.0089 |
| 6 | Ileal Bile Acid Transporter Inhibitor [EPC] | 3 | 0.0066 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 824 | 0.0044 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 194 | 0.0039 |
| 9 | Kinase Inhibitor [EPC] | 2026 | 0.0036 |